α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions

被引:57
作者
Sang, Peng [4 ]
Shi, Yan [4 ]
Lu, Junhao [3 ]
Chen, Lihong [3 ]
Yang, Leixiang [3 ]
Borcherds, Wade [2 ]
Abdulkadir, Sami [4 ]
Li, Qi [1 ]
Daughdrill, Gary [2 ]
Chen, Jiandong [3 ]
Cai, Jianfeng [4 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai 201203, Peoples R China
[2] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA
[4] Univ S Florida, Dept Chem, Tampa, FL 33620 USA
关键词
AROMATIC OLIGOAMIDE FOLDAMERS; STRUCTURE-BASED DESIGN; BETA(3)-PEPTIDE INHIBITORS; TRANSMEMBRANE PORES; BETA-PEPTIDES; P53; AFFINITY; MIMETICS; MDMX; PEPTOIDS;
D O I
10.1021/acs.jmedchem.9b00993
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The use of peptidomimetic scaffolds is a promising strategy for the inhibition of protein-protein interactions (PPIs). Herein, we demonstrate that sulfono-gamma-AApeptides can be rationally designed to mimic the p53 alpha-helix and inhibit p53 MDM2 PPIs. The best inhibitor, with K-d and IC50 values of 26 nM and 0.891 mu M toward MDM2, respectively, is among the most potent unnatural peptidomimetic inhibitors disrupting the p53-MDM2/MDMX interaction. Using fluorescence polarization assays, circular dichroism, nuclear magnetic resonance spectroscopy, and computational simulations, we demonstrate that sulfono-gamma-AApeptides adopt helical structures resembling p53 and competitively inhibit the p53-MDM2 interaction by binding to the hydrophobic cleft of MDM2. Intriguingly, the stapled sulfono-gamma-AApeptides showed promising cellular activity by enhancing p53 transcriptional activity and inducing expression of MDM2 and p21. Moreover, sulfono-gamma-AApeptides exhibited remarkable resistance to proteolysis, augmenting their biological potential. Our results suggest that sulfono-gamma-AApeptides are a new class of unnatural helical foldamers that disrupt PPIs.
引用
收藏
页码:975 / 986
页数:12
相关论文
共 50 条
[41]   The isolation, total synthesis and structure elucidation of chlorofusin, a natural product inhibitor of the p53-MDM2 protein-protein interaction [J].
Clark, Ryan C. ;
Lee, Sang Yeul ;
Searcey, Mark ;
Boger, Dale L. .
NATURAL PRODUCT REPORTS, 2009, 26 (04) :465-477
[42]   Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein Interactions [J].
Zhang, Shiyan ;
Lou, Jianfeng ;
Li, Yafang ;
Zhou, Feilong ;
Yan, Ziqin ;
Lyu, Xilin ;
Zhao, Yujun .
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (15) :10621-10640
[43]   Novel Pyrrolopyrimidine-Based α-Helix Mimetics: Cell-Permeable Inhibitors of Protein-Protein Interactions [J].
Lee, Ji Hoon ;
Zhang, Qi ;
Jo, Sunhwan ;
Chai, Sergio C. ;
Oh, Misook ;
Im, Wonpil ;
Lu, Hua ;
Lim, Hyun-Suk .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (04) :676-679
[44]   NEW PLAYERS IN CANCER THERAPEUTICS: FOCUS ON INHIBITORS OF MDM2-P53 PROTEIN-PROTEIN INTERACTION [J].
Capdevila, J. ;
Cervantes, A. ;
Tabernero, J. .
DRUGS OF THE FUTURE, 2012, 37 (04) :273-281
[45]   Forces mediating protein-protein interactions: a computational study of p53 "approaching" MDM2 [J].
Dastidar, Shubhra Ghosh ;
Madhumalar, Arumugam ;
Fuentes, Gloria ;
Lane, David P. ;
Verma, Chandra S. .
THEORETICAL CHEMISTRY ACCOUNTS, 2010, 125 (3-6) :621-635
[46]   A facile method to screen inhibitors of protein-protein interactions including MDM2-p53 displayed on T7 phage [J].
Ishi, Kazutomo ;
Sugawara, Fumio .
BIOCHEMICAL PHARMACOLOGY, 2008, 75 (09) :1743-1750
[47]   Group-based QSAR and molecular dynamics mechanistic analysis revealing the mode of action of novel piperidinone derived protein-protein inhibitors of p53-MDM2 [J].
Goyal, Sukriti ;
Grover, Sonam ;
Dhanjal, Jaspreet Kaur ;
Tyagi, Chetna ;
Goyal, Manisha ;
Grover, Abhinav .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2014, 51 :64-72
[48]   Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction [J].
Li, Chong ;
Zhan, Changyou ;
Zhao, Le ;
Chen, Xishan ;
Lu, Wei-Yue ;
Lu, Wuyuan .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) :4045-4050
[49]   p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents [J].
Nayak, Surendra Kumar ;
Khatik, Gopal L. ;
Narang, Rakesh ;
Monga, Vikramdeep ;
Chopra, Harish Kumar .
CURRENT CANCER DRUG TARGETS, 2018, 18 (08) :749-772
[50]   MDMX: A novel p53-binding protein with some functional properties of MDM2 [J].
Shvarts, A ;
Steegenga, WT ;
Riteco, N ;
vanLaar, T ;
Dekker, P ;
Bazuine, M ;
vanHam, RCA ;
vanOordt, WV ;
Hateboer, G ;
vanderEb, AJ ;
Jochemsen, AG .
EMBO JOURNAL, 1996, 15 (19) :5349-5357